Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ALDX Hot Sheet
Join SI Premium – FREE
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Ennis (EBF) Misses Q2 EPS by 2c
- UBS Downgrades NAVER Corp. (035420:KS) (NHNCF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
